Alan Tyndall
Alan Tyndall was born on 3/8/1948 in Newcastle Australia and achieved his undergraduate medical degree  at the University of Sydney in 1972. His post graduate qualifications are FRACP, FRCP(Ed), with post graduate experience in Canberra, Sydney and London. In 1991 he was appointed professor and head of the Dept of Rheumatology in the University of Basel, and his recent interests are stem cell therapy of autoimmune diseases and systemic sclerosis  (scleroderma). He has participated in the working party of the ESF sponsored study of investigator initiated trials and the EMA study group regarding third country clinical trials.  He has served on the boards of the EBMT and EULAR and was a founding member and secretary of the EULAR Scleroderma Trials and Research (EUSTAR) group. He is currently secretary and founding member of the World Scleroderma Foundation (based in Basel), chairman of the safety committees of two of 2 NIH sponsored stem cell  trials and is an adjunct professor at the University of Florence, Italy.
Prof Tyndall has published over 230 peer reviewed papers, 100 of which relate to stem cell therapy and 25 book chapters.